ABSTRACT. The mechanisms of Marek's disease virus (MDV) entry to host cells have not yet been analyzed. Heparan sulfate (HS) on the cell surface serves as a receptor for several herpesviruses in mammalian species. In this study, we demonstrated that plaque formation by cell-free MDV is inhibited by the addition of soluble heparin to the cell culture. Moreover, pretreatment of susceptible cells, chicken embryo fibroblasts, with heparinase, partially reduced infectivity of the cell-free MDV. From these results, it was suggested that the MDV entry, at least in the case of cell-free MDV, is dependent on the presence of cell surface glycosaminoglycans, principally HS. KEY WORDS: cell-free MDV, heparan sulfate, heparin.
The primary event of any viral infection is attachment of virus to its host cell. Viral receptors are often involved in defining the host range and specific tissue tropism of a virus. Attachment of herpesviruses to target cells is mediated by viral glycoproteins which are embedded in the virion envelope, and which interact with cellular surface components acting as virus receptors. The first virus found to bind to heparan sulfate (HS) was herpes simplex virus (HSV) [43] , and since then, a number of herpesviruses have been demonstrated to use HS as an initial receptor for their entry. In the cases of the alphaherpesviruses, initial interaction between the virion and the target cell involves binding of glycoprotein C (gC) [37] and/or glycoprotein B (gB) [22] to cell-surface glycosaminoglycans (GAG), in particular, HS, which are components of proteoglycans. This interaction with HS has been observed for HSV-1, and HSV-2 [43] , pseudorabies virus (PRV) [24] , varicella-zoster virus [44] , and bovine herpesvirus 1 (BHV-1) [27] . In addition, the gamma- [40] and betaherpesviruses [10, 35] have been also reported to interact with HS during the attachment. In addition, recent works have shown that HS is also involved in the binding of several other viruses, such as human immunodeficiency virus type 1 [29] , foot-and-mouth disease virus [18] , respiratory syncytial virus [20] , dengue virus [8] , adeno-associated virus type 2 [38] , and Sindbis virus [4] .
Marek's disease virus (MDV), an avian herpesvirus, is the causative agent of Marek's disease (MD), which is characterized by CD4 + T cell lymphoma and nerve enlargement caused by infiltration of lymphocytes and/or lymphoma cells. The pathogenesis of MD can be sequentially divided into three phases: early cytolytic infection; latent infection; and secondary cytolytic infection with immunosuppression and tumor development [26, 32, 34] . Early cytolytic infection occurs mainly in B cells, and latently infected lymphocytes are mainly activated T cells [36] . In addition, target cells for transformation by MDV are mainly CD4 + T cells [34] , suggesting that latent infection in the T cell subsets could be intimately related to the subsequent transformation by MDV. MDVs are highly cell-associated, and the cellfree virus particles are produced only in feather follicle epithelium (FFE) of MDV-infected chickens [6] . However, the mechanism(s) by which MDV attaches to its host cells has not been delineated.
Here, we demonstrated that, cell-free MDVs, experimentally prepared from cell culture in vitro, were infectious to cells not only in vitro but also in vivo. In addition, we also showed that cell surface HS is involved in initial infection for cell-free MDV, determined by plaque inhibition assay using soluble heparin in vitro.
MATERIALS AND METHODS
Virus and cells : Fertile eggs of Shaver 288 White Leghorn chickens were purchased from Hokuren Co., Ltd. (Sapporo, Japan), and chicken embryo fibroblasts (CEF) were obtained from 10-day-old embryos. Attenuated and very virulent MDV serotype 1 (MDV1), CVI988 [30] (Kyoritsushoji Co., Ltd., Tokyo, Japan) and Md5 [42] , respectively, and non-pathogenic MDV serotype 2 (MDV2), SB-1 [33] , were propagated in CEF or chicken kidney cells (CKC). CEF and CKC were grown in modified Eagle's medium containing 0.3% tryptose phosphate broth (TPB/MEM), supplemented with 10% (growth medium) or 1% calf serum (maintenance medium). When the cytopathic effects by viruses were confluent, infected cells were used for the preparation of either the cell-free or cell-associated viruses.
Monoclonal antibodies : To examine whether the monoclonal antibodies (MAbs) can inhibit the plaque formation by MDV, following MAbs were used; M26, which can recognize gC of MDV1 [16] ; M51, which can recognize gB of MDV1 and herpesvirus of turkeys (HVT) [17] . These MAbs were kindly provided from Dr. Ikuta, Osaka University, Osaka, Japan. MAb, 6F11, which can recognize MDV1 gD [28] , was kindly provided from Dr. Jang, the University of Tokyo, Tokyo, Japan. These antibodies were prepared from mouse ascites by the precipitation with 33%-saturated ammonium sulfate. The concentration of MAbs was determined with BCA protein assay reagent (Pierce, Bockford, IL, U.S.A.), and adjusted to 1 mg/ml.
Extraction of cell-free MDV from cultured cells : Supernatant fluids from sonicated CEF or CKC, which were infected with Md5, CVI988, or SB-1, were used as a source of cell-free MDV. Briefly, infected cultures after incubation for 5 to 7 days were drained and rinsed once with phosphatebuffered saline (PBS). The cultures were treated with trypsin-versene solution, transferred to tubes, washed with SPGA-SBT (0.4 mM KH 2 PO 4 , 7.2 mM K 2 HPO 4 , 7.46% sucrose, 1% BSA, 10% sorbitol and 0.92 mg/ml sodium glutamate), and disrupted in SPGA-SBT by sonication (Astrason Ultrasonic Processor, Misonix Inc., NY) at a 50% probe intensity (20 kHz) for 1 min [9] . Then, the sonicated solutions were centrifuged at 2,000 × g for 5 min to remove the cell debris, and the supernatants were aliquoted and stored at -80°C. Viral titers were determined by plaque assays. Duplicate monolayer cultures of CEF grown on 60 mm plastic petri-dishes were inoculated with 0.1 ml of the cell-free virus and 0.9 ml of media. Cultures were incubated at 37°C in a humid atmosphere containing 5% CO 2 for 1 hr. Then, inocula were removed and cells were washed, and cultured with 3 ml of fresh media. Plaques in the cell-free virus-infected cultures were counted at 7 days post inoculation (pi.).
Inoculation of cell-free MDV to chickens : Five-day-old Shaver 288 White Leghorn chickens, purchased from Hokuren Co., Ltd., were inoculated intraperitoneally with cell-free MDV (10,000 plaque forming units (PFU)/ chicken). These chickens were sacrificed at 7 days pi., and the spleens were used for the extraction of total cellular DNA to detect the MDV genome and for virus re-isolation.
Extraction of total cellular DNA and polymerase chain reaction (PCR) : Total cellular DNAs were extracted from the chicken splenocytes with standard procedure [31] . The cells were resuspended in 0.5 ml of lysis buffer (20 mM Tris pH 8.0, 25 mM EDTA, 100 mM NaCl and 0.5% SDS) containing 2 mg/ml of proteinase K, and incubated at 37°C overnight. The lysates were deproteinized by extracting once with phenol and once with phenol-chloroform-isoamylalcohol (25:24:1). To the resultant supernatants, 2.5 volumes of ethyl alcohol and 10 -1 volume of 5 M NaCl were added, and total cellular DNA was precipitated at -20°C for 2 hr.
Total cellular DNAs were used for PCR to detect the MDV-specific nucleotide sequence. Amplification was carried out as follows: an initial cycle at 94°C for 5 min, 35 cycles of 1 min at 94°C, 1 min at 53°C and 2 min at 72°C, and a final extension at 72°C for 5 min. The oligonucleotide primers specific to the 132-bp direct repeat in the MDV genome, primers DR1 (5'-TGTAGTTGGAGTTCGG-TATT-3') and DR2 (5'-CAAAGGAATTACTGGACT-3') were designed from the nucleotide sequence of strain GA (MDV1) reported previously [2] . By using these primers, the size of amplified DNA was 479 bp (including 2 copies of the 132-bp direct repeat) in pathogenic MDV1 (i.e., Md5) while multiple fragments were amplified ranging from 611 to 1,403 bp (including 3 to 9 copies of the direct repeat) in non-pathogenic MDV1 (i.e., CVI988) [1] . The primers specific to pp38 gene of MDV1 [11] , primers P1 (5'-GTGATG-GAATTCGAAGCAGA-3') and P2 (5'-CCGACTTTC-GTCAAGATGTT-3') were also used to detect Md5 viral DNA (the size of amplified DNA fragment was 390 bp). The amplified fragments were separated on an agarose gel and visualized by the staining with ethidium bromide.
Plaque-forming inhibition assays : Since HS proteoglycans, which carry glycans similar to heparin, are present on the surface of the most types of vertebrate cells, we examined the possibility that HS could serve as a receptor for MDV. Various concentrations of heparin (Hoechst Marion Roussel, Tokyo, Japan; in 50% of SPGA-SBT and 50% of medium) was added to CEF simultaneously or sequentially with cell-free MDV or lymphocytes from chickens infected with MDV. After incubation at 37°C for 1 hr, the inoculum was removed and the cells were washed three times with TPB/MEM, and incubated at 37°C in a humid atmosphere containing 5% CO 2 . At 7 days pi., numbers of plaques were counted under a light microscope.
CEF were also treated with heparinase (H2519, Sigma) to cleave heparan sulfate residues on the cell surface for approximately 20 hr before the infection of cell-free MDVs, or treated with various concentrations of MAbs against MDV1. Then, these treated cells were inoculated with cellfree MDV or infected lymphocytes, incubated, and plaques were counted as described above. None of these agent and enzyme treatments caused any detachment of cells from the monolayers.
RESULTS

Infectivity of cell-free MDV in vitro and in vivo:
Cellfree MDV1 prepared by ultrasonication of infected cell cultures was not contaminated with any living cells, confirmed under a microscopy, though this preparation was not filtrated. This cell-free MDV was shown to infect CEF monolayers, as determined by plaque formation (data not shown). Next, we determined whether the cell-free MDV1 can infect splenocytes in vivo. At 7 days after chickens were inoculated with the cell-free Md5 preparation, the MDV1-specific DNAs corresponding to the pp38 gene and 132-bp direct repeat were amplified by PCR from total cellular DNA extracted from splenocytes of these chickens (Fig. 1) . In addition, MDV was reisolated from spleen cells of chickens inoculated with the cell-free Md5. The titer of MDV isolated (100 PFU/1 × 10 5 splenocytes) was almost same as that from chickens inoculated with cell-associated Md5 [14] . These results indicate that even cell-free MDV1 preparation was able to efficiently establish infection in chicken spleen cells in vivo. Thus, sonic extraction from infected cell cultures may be useful to prepare cell-free MDVs for studies of molecular events of the MDV infection in vitro and in vivo.
Inhibition of plaque formation by heparin or heparinase treatment : To determine whether the addition of exogenous soluble heparin could inhibit the plaque formation or not, CEF were infected with cell-free or cell-associated MDVs in the presence of heparin. Figure 2 shows that exogenous heparin significantly inhibited the plaque formation by the cell-free MDVs. In these experiments, we tested the effects of heparin at concentration ranging from 2.5 to 40 units per ml. Plaque formation of cell-free Md5, CVI988 or SB-1 was inhibited by heparin in a dose-dependent manner. Total cellular DNA from CKC infected with cell-associated MDV1 strain, Md5 (Md5-CK), or splenocytes from chickens inoculated with cell-free Md5 (CF-Md5-Sp), was used as a template for PCR amplification. PCR was performed using primer sets described in the Materials and Methods. PCR was also performed with sample from splenocytes from normal chickens (NorSp). Lane M represents a size marker (a mixture of HindIII-digested lambda DNA and HaeIIIdigested øX174DNA). Fig. 2 . Effects of heparin on plaque formation by cell-free and cell-associated MDVs. The mixture of various concentrations of heparin and approximately 100 to 200 PFU of strain Md5, CVI988, or SB-1 were inoculated to CEF monolayers. After incubation at 37°C for 1 hr, the inoculum was removed and the cells were washed three times with TPB/MEM. Plaques were counted after 7 days of incubation. Independent experiments were performed in duplicate or triplicate wells, and the average percents of inhibition were shown.
Higher doses of heparin (10 units per ml or more) almost completely inhibited plaque formation by cell-free Md5. A marked inhibition of plaque formation of CVI988 was observed in the presence of lower doses of heparin, while only a moderate inhibition of plaque formation by SB-1 was shown even in the presence of 40 units per ml of heparin. In contrast to cell-free MDV, infectivity of cell-associated MDV was less inhibited by the addition of heparin whose maximum inhibition reached only about 15%. Cell surface GAGs can be removed enzymatically. Thus, in the next experiment, CEF were treated with various concentrations of the heparinase which degrades HS to study its effects on the ability of cells to adsorb virus. Digestion with heparinase before virus adsorption resulted in the partial reduction of numbers of plaques induced by cell-free Md5 with a rate of 33% at the 2.5 units per ml (Fig. 3) . The effects of the heparinase on cell-free Md5 infection to CEF were due to the alteration of the cell surface, and not of the virus particles, since remaining heparinase was removed by washing before virus materials were added. On other hand, the addition of MAbs against gB, gC or glycoprotein D (gD) of MDV1 to CEF simultaneously with cell-free Md5 did not affect on plaque formation (Fig. 4) .
DISCUSSION
The MDV-host cell interaction is a complex event due to its cell-associated nature, and cell-free virus is recovered only from FFE [6] . Very little is known concerning the molecular events of the entry of both cell-free and cell-associated virus into cells, and the virus receptors have not been identified. Lack of knowledge of receptors for the MDV entry, which helps to determine host range and tissue tropism, will certainly limit our understanding of the cascade of events in the early pathogenic processes. Various extraction methods have been described for cell-free MDVs from infected cell cultures, but were reported to be successful only for in vitro infection [3, 5, 7, 9, 12, 23] . Here, we reported that cell-free MDV prepared in this study was high titer of infectious virus, and useful to study the infection mechanism in vivo as well as in vitro.
The initial step of the infection of alpha-herpesviruses, such as HSV-1, PRV, or BHV-1, to host cells is the attachment of virions to HS on the cell surface, which can be inhibited by the addition of heparin to the inoculum [21, 24, 43] . Infections of cell-free MDVs were also inhibited by the addition of heparin in a dose-dependent manner (Fig. 2) , indicating that initial attachment of MDVs to cells was similar to those of other herpesviruses, at least in the infection of cell-free MDV. In addition, pre-treatment of host cells with heparinase, which can digest some cell surface GAG, partially inhibited the infection of cell-free Md5 (Fig. 3) . These results show that GAG can act as a receptor for cellfree MDVs. On the other hand, the heparin treatment only slightly inhibited plaque formation by cell-associated MDVs (Fig. 2) . The reason for this observation remains to be determined. That may be due to the presence of other Plaque assays were performed as described in Fig. 2 . Independent experiments were performed in duplicate or triplicate wells, and the average percents of inhibition were shown. It has been reported that infectious laryngotracheitis virus attaches to its host cell in a heparin-independent manner, distinct from other alpha herpesviruses [19] .
In Fig. 4 , we showed that three MAbs against MDV1 glycoproteins did not inhibit plaque formation of cell-free Md5, which may express these glycoproteins on their virus particle. This result suggests that the other glycoproteins, such as glycoprotein H-glycoprotein L (gH-gL), is involved in the entry process of cell-free Md5, as reported in HSV [15] . The reason why MAb against gB did not inhibit plaque formation of cell-free Md5 remains unknown although this MAb has been reported to partially neutralized MDV [17] . Viral proteins are known to be required for binding and membrane fusions. GAG may interact with more than one viral proteins. For example, gB and gC bind HS [22, 37] and gD binds herpesvirus entry mediators A to D (HveA, HveB, HveC and HveD) [13, 25, 41] . It would be necessary to find all of the molecule(s) participating in the binding of MDV in order to define the mechanism of virus-cell interaction during MDV infection.
We showed that the addition of heparin to cell-free MDVs inoculum interferes with its plaque formation in the cell culture. The heparin, an analog including the characteristic of binding cell-free MDVs in our results, may be applicable for the purification of infectious cell-free MDVs by affinity chromatography, and for further analysis [39] .
